News & Events
March 10, 2021
View Now: IBD Biomarker Regulatory Science WebinarWednesday, March 10, 10 a.m. ET The 3TR IMI project consortium and Critical Path Institute invite you to participate in the IBD Biomarker Regulatory Science Webinar. Together, with a collection of public research institutes, industry members and patient advocates, we will align on how to progress biomarkers through the FDA & EMA’s regulatory acceptance process. This webinar......
February 17, 2021
WEBINAR: eCOA: Getting Better Together Initiative – An Update from C-Path’s PRO Consortium and ePRO Consortium
This webinar was hosted by the DIA Study Endpoints Community and presented jointly by the PRO Consortium and ePRO Consortium.
Date: Wednesday, February 17, 2021
February 9, 2021 - February 11, 2021
SHIP-MD 2021 Virtual Workshop
Join Us February 9th, 10th, 11th 2021
Free Public Virtual Meeting and Workshop
All stakeholders interested in pediatric medical device development are invited to a dynamic 3-day virtual public meeting developed and guided by a multi-stakeholder group including C-Path, the U.S. Food and Drug Administration, AdvaMed, American Academy of Pediatrics, and leaders of pediatric health systems.
January 21, 2021 - January 21, 2021
Watch now: RDCA-DAP and EATRIS Present Rare Disease Drug Develoment Webinar
January 21, 2021 | 5:00 p.m. – 6:30 p.m. CET
Data Sharing and Analysis to Support Rare Disease Drug Development
The European Infrastructure for Translational Medicine, EATRIS, has invited the Rare Disease Cures Accelerator-Data and Analytics Platform team to present as part of its webinar series, EATx, to introduce RDCA-DAP to the European academic and industry audience. The webinar will discuss how RDCA-DAP works with European entities and how data sharing within Europe, and between Europe and other countries, can be achieved with RDCA-DAP.
October 29, 2020
COVID-19: Risk Assessment and Mitigation Strategies for the Collection of PRO Data through Clinical Sites – Lessons Learned
This webinar provides an update from sponsors and eCOA providers as they discuss lessons learned from managing clinical trials that originally planned for in-person collection of ePRO data through clinical sites. Due to public health concerns, many patients are either unable or unwilling to travel to sites for scheduled visits or sites have had to close. In March 2020, ePRO Consortium and PRO Consortium member representatives collaborated on risk assessment and mitigation strategies for clinical trials in response to COVID-19. This webinar discusses lessons learned, how the initial recommendations performed, and how sponsors and eCOA providers are applying these learnings to future trials …